Companies

Foghorn Therapeutics Inc. (FHTX) SEC filings

CIK 0001822462 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)30.9 M34.2 M19.2 M
Net income (USD)-98.4 M-108.9 M-101.3 M
Diluted EPS (USD/shares)-1.18-2.34-2.62

Latest filings

FiledFormDescriptionPeriod
2026-10-053OWNERSHIP DOCUMENT2026-10-01
2026-10-05SCHEDULE 13G/ASCHEDULE 13G/A
2026-10-018-K8-K items 2.05,7.01,9.012026-09-25
2026-08-0610-Q10-Q2026-06-30
2026-08-068-K8-K items 2.02,7.01,9.012026-08-06
2026-06-254PRIMARY DOCUMENT2026-06-24
2026-06-254PRIMARY DOCUMENT2026-06-24
2026-06-254PRIMARY DOCUMENT2026-06-24
2026-06-254PRIMARY DOCUMENT2026-06-24
2026-06-254PRIMARY DOCUMENT2026-06-24
2026-06-254PRIMARY DOCUMENT2026-06-24
2026-06-254PRIMARY DOCUMENT2026-06-24
2026-06-254PRIMARY DOCUMENT2026-06-24
2026-06-254PRIMARY DOCUMENT2026-06-24
2026-06-248-K8-K items 5.072026-06-24
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-0710-Q10-Q2026-03-31
2026-05-078-K8-K items 2.02,7.01,9.012026-05-07
2026-05-06SCHEDULE 13G/ASCHEDULE 13G/A
2026-04-30ARSARS2025-12-31
2026-04-30DEFA14ADEFA14A
2026-04-30DEF 14ADEF 14A2026-06-24
2026-04-218-K8-K items 7.01,8.01,9.012026-04-21
2026-04-134PRIMARY DOCUMENT2026-04-09

Forms on file (last 1,000): 4 125, 8-K 89, 3 29, 10-Q 18, CORRESP 8, UPLOAD 7, DEF 14A 6, S-8 6. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=FHTX (0.002 USD), /gw/filings/filings?ticker=FHTX&form=8-K, /gw/filings/facts?ticker=FHTX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange